Pancreatic Cancer is an aggressive and quickly spreading disease where few symptoms exist until the cancer is very advanced, and because of this, pancreatic cancer has a poor prognosis even with early detection. It occurs when malignant cells form in the tissues of the pancreas, typically in the exocrine cells (the cells that produce digestive juices). Pancreatic cancer typically affects individuals who are African American, who are overweight, have diabetes, smoke, have pancreatitis, or have a family history of pancreatic cancer. Treatments for pancreatic cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and clinical trials. Stage I of pancreatic cancer is divided into two subgroups: A and B. In stage IA, the tumor is confined to the pancreas (has not spread to nearby lymph nodes or other locations) and is less than 2 cm in size. Stage IB is defined as when the tumor has not spread to other locations and the tumor is larger than 2 cm in size.
Stage I Pancreatic Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage I Pancreatic Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 238 products for the study of Stage I Pancreatic Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.